← Back

ChemoMetec A/S

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops XcytoMatic 30 cell counter and Xcyto 5, a versatile cell analyzer. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.

Price · split & dividend adjusted
News & notes moving 0DZ0.LSE
0DZ0.LSE

ChemoMetecとRoche Diagnostics、バイオプロセスモニタリング接続で協業契約を締結

ChemoMetecとRoche Diagnosticsは、Roche Cedex® Bio AnalyzerとChemoMetec Xcytomatic® 30細胞計数分析装置を接続するキットを開発するための協業契約を締結した。この契約は2026年2月に締結された意向書に基づくもので、接続ソリューションの開発とその後の商業化の両方を対象としている。Rocheが接続キットの設計、検証、バリデーションを担当し、両装置間のシームレスなハードウェアおよびソフトウェア統合を目指す。両社は統合ソリューションを共同でプロモーションする一方、各社は自社の分析装置の唯一の販売者であり続ける。
Yahoo Finance·16d続きを読む ▾